サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765434

硝子体タンポナーデの世界市場

Vitreous Tamponades

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
硝子体タンポナーデの世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

硝子体タンポナーデの世界市場は2030年までに1億710万米ドルに達する見込み

2024年に8,990万米ドルと推定される硝子体タンポナーデの世界市場は、2030年には1億710万米ドルに達し、分析期間2024-2030年のCAGRは3.0%で成長すると予測されます。本レポートで分析したセグメントの1つである気体タンポナーデは、CAGR 2.8％を記録し、分析期間終了までに5,090万米ドルに達すると予測されます。液体タンポナーデ分野の成長率は、分析期間中CAGR 3.1％と推定されます。

米国市場は2,440万米ドルと推定、中国はCAGR 2.8％で成長予測

米国の硝子体タンポナーデ市場は2024年に2,440万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 2.8%で推移し、2030年には1,710万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9％と2.6％と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の硝子体タンポナーデ市場- 主要動向と市場促進要因を探る

なぜ硝子体タンポナーデは眼科手術に不可欠なのか？

硝子体タンポナーデは現代の眼科手術に欠かせないものとなっており、複雑な網膜の状態を管理し、手術結果を成功に導く上で重要な役割を果たしています。しかし、これらの物質が眼科分野で重要なのはなぜでしょうか？硝子体タンポナーデは、網膜剥離の修復、黄斑円孔の手術、糖尿病性網膜症の管理などの手術後に特に、網膜を支え、その下の組織に対する位置を維持するために網膜硝子体手術中に使用される特殊な眼内物質です。タンポナーデは網膜を一時的に支え、網膜剥離の再発や合併症のリスクを最小限に抑えながら、網膜が適切に治癒するようにします。タンポナーデには、ガス（六フッ化硫黄、パーフルオロプロパンなど）やシリコーンオイルなど様々な形態があり、それぞれ特定の手術適応や患者の状態に基づいて選択されます。

硝子体タンポナーデの需要が急増しているのは、網膜疾患の有病率が上昇し、これらの疾患の治療に高度な手術技術が採用されるようになっているためです。網膜剥離、黄斑円孔、増殖性硝子体網膜症は、効果的な管理に硝子体タンポナーデを必要とする最も一般的な疾患の一つです。これらの症例では、タンポナーデが体内包帯の役割を果たし、表面張力と圧力を発揮して、術後の治癒期に網膜を安定させる。タンポナーデの選択は、網膜裂孔の大きさや位置、増殖組織の有無、術後に患者が特定の頭位を維持できるかどうかなどの要因によって決まる。これらのタンポナーデの使用により、網膜手術の成功率は著しく向上し、合併症の発生率は減少し、患者の視力転帰は改善しました。網膜疾患とその治療法に対する認識が高まるにつれ、硝子体タンポナーデは眼科分野でさらに重要な役割を果たすようになっています。

技術の進歩は硝子体タンポナーデの性能をどのように高めていますか？

硝子体タンポナーデ市場は、これらの物質の有効性、安全性、汎用性を高めるいくつかの技術的進歩を目の当たりにしてきました。しかし、これらの開発の原動力となっている主な発展とは何でしょうか？最も重要な進歩の一つは、生体適合性、安定性、使いやすさを向上させるためのタンポナーデ材料の改良です。例えば、ペルフルオロプロパン（C3F8）やヘキサフルオロエタン（C2F6）などの長時間作用型ガスタンポナーデの開発により、外科医は網膜を長時間支持できるようになり、再手術の必要性が減少しました。これらのガスはゆっくりと膨張し、何週間も眼内に留まるため、網膜に一定の圧力をかけることができ、特に大きな網膜剥離や増殖性硝子体網膜症の場合に有益です。さらに、シリコーンオイルの処方の進歩により、高密度と低密度のものが作られるようになり、浮力特性が異なり、網膜の位置のコントロールがしやすくなりました。例えば、高密度のシリコーンオイルは、網膜下裂や網膜剥離が存在する複雑な症例に使用され、過剰な上方浮力を与えずに標的をサポートします。

もう一つの重要な技術革新は、石油・ガスとシリコーンオイルの両方の特性を統合したコンビネーション・タンポネードの開発です。これらのタンポナーデは、一時的なガスサポートと長期的なシリコーンオイルの安定性の両方を提供するため、眼圧や表面張力の程度が異なる複雑な網膜手術の管理に理想的です。タンポナーデ送達システムの革新により、手術中の使いやすさも向上しました。プレフィルドシリンジと正確に計量された投与量の導入により、タンポナーデの投与が簡素化され、汚染のリスクが軽減され、一貫した結果が得られるようになりました。自動混合・供給装置の使用により、ガス濃度の精度がさらに向上し、外科医は個々の患者のニーズに合わせた最適なタンポナーデ効果を達成できるようになりました。このような技術的進歩は、硝子体タンポナーデの性能を向上させただけでなく、その適用範囲を拡大し、外科医がより複雑で困難な症例に自信を持って取り組み、成功させることを可能にしています。

どのような市場動向が眼科診療における硝子体タンポナーデの採用を促進していますか？

いくつかの新たな市場動向が、眼科診療における硝子体タンポナーデの採用を形成しており、網膜疾患の管理における外科医と患者のニーズの進化を反映しています。最も顕著な動向のひとつは、特に高齢化社会における網膜疾患の有病率の増加です。加齢黄斑変性症（AMD）、糖尿病性網膜症、網膜静脈閉塞症などの疾患は、平均寿命が延び、糖尿病や高血圧などの生活習慣因子が蔓延するにつれて、より一般的になってきています。これらの疾患は網膜剥離や黄斑円孔などの合併症を引き起こすことが多く、硝子体タンポナーデを用いた外科的介入が必要となります。網膜の健康に対する意識が高まり、高度な手術方法が利用できるようになったことで、より多くの患者がタイムリーな治療を求めるようになり、先進国市場でも新興市場でも硝子体タンポナーデの需要を促進しています。

硝子体タンポナーデの採用を促進するもう一つの重要な動向は、低侵襲網膜硝子体手術技術の台頭です。マイクロ切開硝子体手術（MIVS）の進歩により、網膜手術はより低侵襲になり、回復時間が短縮され、患者の転帰が改善されました。硝子体タンポナーデはこれらの手術に不可欠な要素であり、手術中および手術後に網膜に必要なサポートを提供します。患者がその日のうちに帰宅できる外来網膜硝子体手術の動向は、迅速な作用と信頼できる結果を提供するタンポナーデの需要をさらに高めています。この変化は、北米や欧州のような先進地域で特に顕著であり、ヘルスケアシステムは費用対効果が高く患者に優しい手術ソリューションを重視しています。さらに、遠隔眼科や網膜状態の遠隔モニタリングの採用が増加していることから、術後のサポートを拡大するタンポナーデの必要性が浮き彫りになり、患者が頻繁に来院しなくても網膜の安定した位置と治癒を維持できるようになっています。これらの動向は、よりアクセスしやすく、効率的で、患者中心の網膜治療への幅広いシフトを強調するものであり、硝子体タンポナーデを現代の眼科診療に不可欠なツールとして位置づけています。

硝子体タンポナーデ世界市場の成長を促進する要因は？

世界の硝子体タンポナーデ市場の成長は、網膜疾患の発生率の上昇、手術手技の進歩、効果的な術後サポートソリューションに対する需要の増加など、いくつかの要因によって牽引されています。主な成長要因の1つは、世界中で視覚障害や失明の主な原因となっている網膜疾患の負担増です。網膜剥離、黄斑円孔、糖尿病性網膜症などの疾患は、視力低下を防ぐためにタイムリーな外科的介入を必要とし、硝子体タンポナーデは外科的転帰を成功させるために重要な役割を果たします。このような疾患に対する認識と外科的治療の選択肢が増えるにつれ、より多くの患者が医療介入を求めるようになり、硝子体タンポナーデの需要を牽引しています。特に新興国市場では老年人口が増加しており、加齢に伴う網膜疾患が蔓延して専門的な手術管理が必要になっていることも市場開拓に貢献しています。

また、タンポナーデの材料や送達システムの技術革新が進んでいることも大きな成長要因となっています。生体適合性が向上し、保持時間が長く、浮力特性が調整された先進的なタンポナーデの開発により、外科医は複雑な症例でより良い結果を得ることができるようになりました。プレフィルドシリンジと標準化された剤形が利用可能になったことで、手術室でのタンポナーデの使用が合理化され、準備時間が短縮され、汚染のリスクが最小限に抑えられました。このような技術革新により、タンポナーデはより身近で使いやすくなり、より幅広い眼科診療での採用が促進されています。さらに、患者の安全性と術後ケアを重視する傾向が強まったことで、信頼性の高いサポートと最小限の合併症を提供するタンポナーデの使用が増加しています。保険償還政策、ヘルスケア支出の増加、新興市場における眼科手術センターの拡大により、世界の硝子体タンポナーデ市場は持続的な成長を遂げようとしています。

また、個別化医療の動向やオーダーメイド手術ソリューションの市場開拓も市場の追い風となっています。網膜手術が個々の患者のニーズに合わせて行われるようになるにつれて、特定の解剖学的・病理学的状態に適応できるタンポナーデに対する需要が高まっています。このため、さまざまな手術要件に対応する新しいタンポナーデの配合や組み合わせが導入され、手術結果を最適化するための選択肢が外科医に広がっています。製薬企業や医療機器企業による研究開発への投資が増加していることから、この分野での技術革新がさらに促進され、より優れた特性と幅広い用途を備えた次世代タンポナーデの創出につながると期待されています。網膜手術の件数が増加し続け、技術の進歩によって硝子体タンポナーデの使用範囲が拡大する中、世界市場は、臨床需要、技術革新、進化するヘルスケアプラクティスのダイナミックな相互作用によって、力強い成長を遂げるものと思われます。

セグメント

最終用途（病院、眼科クリニック）;製品（気体タンポナーデ、液体タンポナーデ）

調査対象企業の例

  • AL.CHI.MI.A. Srl
  • Carl Zeiss Meditec AG
  • Dutch Ophthalmic Research Center International BV（D.O.R.C.）
  • Fluron GmbH
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16896

Global Vitreous Tamponades Market to Reach US$107.1 Million by 2030

The global market for Vitreous Tamponades estimated at US$89.9 Million in the year 2024, is expected to reach US$107.1 Million by 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis period. Growth in the Liquid Tamponades segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$24.4 Million While China is Forecast to Grow at 2.8% CAGR

The Vitreous Tamponades market in the U.S. is estimated at US$24.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$17.1 Million by the year 2030 trailing a CAGR of 2.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Vitreous Tamponades Market - Key Trends & Growth Drivers Explored

Why Are Vitreous Tamponades Essential in Ophthalmic Surgeries?

Vitreous tamponades have become an integral part of modern ophthalmic surgeries, playing a crucial role in managing complex retinal conditions and ensuring successful surgical outcomes. But what exactly makes these substances so important in the field of ophthalmology? Vitreous tamponades are specialized intraocular substances used during vitreoretinal surgeries to support the retina and maintain its position against the underlying tissue, particularly after procedures like retinal detachment repair, macular hole surgery, and diabetic retinopathy management. They provide temporary support to the retina, allowing it to heal properly while minimizing the risk of recurrent detachment or complications. Tamponades are available in various forms, such as gases (e.g., sulfur hexafluoride and perfluoropropane) and silicone oils, each chosen based on the specific surgical indication and patient condition.

The demand for vitreous tamponades has surged due to the rising prevalence of retinal disorders and the growing adoption of advanced surgical techniques for treating these conditions. Retinal detachment, macular holes, and proliferative vitreoretinopathy are among the most common conditions that require vitreous tamponades for effective management. In these cases, tamponades act as internal bandages, exerting surface tension and pressure to stabilize the retina during the post-operative healing phase. The choice of tamponade depends on factors such as the size and location of the retinal tear, the presence of proliferative tissue, and the patient’s ability to maintain specific head positioning post-surgery. The use of these tamponades has significantly improved the success rates of retinal surgeries, reducing the incidence of complications and enhancing visual outcomes for patients. As awareness of retinal diseases and their treatment options continues to grow, vitreous tamponades are poised to play an even more vital role in the field of ophthalmology.

How Are Technological Advancements Elevating the Performance of Vitreous Tamponades?

The vitreous tamponades market has witnessed several technological advancements that have enhanced the efficacy, safety, and versatility of these substances. But what are the key innovations driving these developments? One of the most significant advancements is the refinement of tamponade materials to improve their biocompatibility, stability, and ease of use. For example, the development of long-acting gas tamponades, such as perfluoropropane (C3F8) and hexafluoroethane (C2F6), has enabled surgeons to provide extended support to the retina, reducing the need for reoperations. These gases expand slowly and remain in the eye for weeks, exerting consistent pressure on the retina, which is particularly beneficial in cases of large retinal detachments or proliferative vitreoretinopathy. Additionally, advancements in the formulation of silicone oils have led to the creation of high-density and low-density variants, which offer different buoyancy properties and better control over retinal positioning. High-density silicone oils, for instance, are used in complex cases where inferior retinal tears or detachments are present, providing targeted support without excessive upward buoyancy.

Another critical innovation is the development of combination tamponades that integrate the properties of both gas and silicone oil. These combination tamponades provide both temporary gas support and long-term silicone oil stability, making them ideal for managing complicated retinal surgeries that require varying degrees of intraocular pressure and surface tension. Innovations in tamponade delivery systems have also enhanced their usability during surgery. The introduction of pre-filled syringes and precisely measured dosages has simplified the administration of tamponades, reducing the risk of contamination and ensuring consistent outcomes. The use of automated mixing and delivery devices has further improved the accuracy of gas concentrations, allowing surgeons to achieve optimal tamponade effects tailored to individual patient needs. These technological advancements have not only improved the performance of vitreous tamponades but have also expanded their applicability, enabling surgeons to tackle more complex and challenging cases with greater confidence and success.

What Market Trends Are Driving the Adoption of Vitreous Tamponades in Ophthalmic Practices?

Several emerging market trends are shaping the adoption of vitreous tamponades in ophthalmic practices, reflecting the evolving needs of surgeons and patients in managing retinal diseases. One of the most prominent trends is the increasing prevalence of retinal disorders, particularly among aging populations. Conditions like age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion are becoming more common as life expectancy increases and lifestyle factors such as diabetes and hypertension become more prevalent. These conditions often lead to complications such as retinal detachments or macular holes, necessitating surgical intervention with the use of vitreous tamponades. The growing awareness of retinal health and the availability of advanced surgical options have encouraged more patients to seek timely treatment, driving demand for vitreous tamponades in both developed and emerging markets.

Another key trend driving the adoption of vitreous tamponades is the rise of minimally invasive vitreoretinal surgery techniques. Advances in microincision vitrectomy surgery (MIVS) have made retinal surgeries less invasive, reducing recovery times and improving patient outcomes. Vitreous tamponades are essential components of these procedures, providing the necessary support to the retina during and after surgery. The trend towards outpatient vitreoretinal surgeries, where patients can return home the same day, has further boosted the demand for tamponades that offer rapid action and reliable results. This shift is particularly evident in developed regions, such as North America and Europe, where healthcare systems emphasize cost-effective and patient-friendly surgical solutions. Additionally, the increasing adoption of teleophthalmology and remote monitoring of retinal conditions has highlighted the need for tamponades that provide extended post-operative support, enabling patients to maintain stable retinal positioning and healing without frequent in-person visits. These trends underscore a broader shift towards more accessible, efficient, and patient-centered retinal care, positioning vitreous tamponades as essential tools in the modern ophthalmic practice.

What Factors Are Driving the Growth of the Global Vitreous Tamponades Market?

The growth in the global vitreous tamponades market is driven by several factors, including the rising incidence of retinal disorders, advancements in surgical techniques, and the increasing demand for effective post-operative support solutions. One of the primary growth drivers is the growing burden of retinal diseases, which are a leading cause of visual impairment and blindness worldwide. Conditions such as retinal detachment, macular hole, and diabetic retinopathy require timely surgical intervention to prevent vision loss, and vitreous tamponades play a crucial role in ensuring successful surgical outcomes. As awareness of these conditions and the availability of surgical treatment options increases, more patients are seeking medical intervention, driving the demand for vitreous tamponades. The expanding geriatric population, particularly in developed regions, has also contributed to market growth, as age-related retinal conditions become more prevalent and require specialized surgical management.

Another significant growth driver is the ongoing innovation in tamponade materials and delivery systems. The development of advanced tamponades with improved biocompatibility, longer retention times, and tailored buoyancy properties has enabled surgeons to achieve better results in complex cases. The availability of pre-filled syringes and standardized dosage forms has streamlined the use of tamponades in the operating room, reducing preparation time and minimizing the risk of contamination. These innovations have made tamponades more accessible and easier to use, encouraging their adoption across a wider range of ophthalmic practices. Additionally, the growing emphasis on patient safety and post-operative care has led to increased use of tamponades that offer reliable support and minimal complications. With supportive reimbursement policies, increasing healthcare expenditure, and the expansion of ophthalmic surgical centers in emerging markets, the global vitreous tamponades market is poised for sustained growth.

The market is also benefiting from the trend towards personalized medicine and the development of customized surgical solutions. As retinal surgeries become more tailored to individual patient needs, the demand for tamponades that can be adapted to specific anatomical and pathological conditions is increasing. This has led to the introduction of new tamponade formulations and combinations that cater to different surgical requirements, providing surgeons with more options to optimize outcomes. The rising investment in research and development by pharmaceutical and medical device companies is expected to further drive innovation in the field, leading to the creation of next-generation tamponades with enhanced properties and broader applications. As the number of retinal surgeries continues to rise and technological advancements expand the scope of vitreous tamponade use, the global market is set to experience robust growth, driven by a dynamic interplay of clinical demand, technological innovation, and evolving healthcare practices.

SCOPE OF STUDY:

The report analyzes the Vitreous Tamponades market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Ophthalmology Clinics); Product (Gaseous Tamponades, Liquid Tamponades)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • AL.CHI.MI.A. Srl
  • Carl Zeiss Meditec AG
  • Dutch Ophthalmic Research Center International BV (D.O.R.C.)
  • Fluron GmbH
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vitreous Tamponades - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Retinal Detachments and Macular Holes Drives Demand for Vitreous Tamponades
    • Increased Adoption of Vitreous Tamponades in Vitreoretinal Surgeries Expands Addressable Market
    • Surge in Demand for Vitreous Tamponades in Diabetic Retinopathy and Macular Edema Treatment Fuels Market Growth
    • Technological Advancements in Gas and Liquid Vitreous Tamponades Propel Market Expansion
    • Surge in Use of Vitreous Tamponades in Trauma and Ocular Injury Management Expands Market Opportunities
    • Technological Innovations in Perfluorocarbon and Silicone Oil Tamponades Propel Market Growth
    • Rising Focus on Reducing Postoperative Complications and Intraocular Pressure Changes Drives Adoption of Vitreous Tamponades
    • Surge in Adoption of Vitreous Tamponades in Proliferative Vitreoretinopathy (PVR) Treatment Fuels Market Growth
    • Surge in Demand for Vitreous Tamponades in Refractive Surgery Complications Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vitreous Tamponades Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vitreous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vitreous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vitreous Tamponades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Gaseous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Gaseous Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Gaseous Tamponades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Liquid Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Liquid Tamponades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Liquid Tamponades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ophthalmology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ophthalmology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ophthalmology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • JAPAN
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • CHINA
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • EUROPE
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Vitreous Tamponades by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Vitreous Tamponades by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • FRANCE
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • GERMANY
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Europe 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Europe 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vitreous Tamponades Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Asia-Pacific 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Asia-Pacific 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Vitreous Tamponades by Product - Gaseous Tamponades and Liquid Tamponades Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of World 15-Year Perspective for Vitreous Tamponades by Product - Percentage Breakdown of Value Sales for Gaseous Tamponades and Liquid Tamponades for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Vitreous Tamponades by End-Use - Hospitals and Ophthalmology Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of World 15-Year Perspective for Vitreous Tamponades by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ophthalmology Clinics for the Years 2015, 2025 & 2030

IV. COMPETITION